Vaxcyte, Inc. (PCVX)

71.38 +6.36 (+9.79%) USD  |  NASDAQ  |  Oct 09, 16:00
71.27 -0.11 (-0.15%) After-Hours: 20:00
More

Vaxcyte Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for PCVX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
October 08, 2026 --
October 06, 2026 --
September 25, 2026 --
August 17, 2026 --
August 06, 2026 --
August 05, 2026 --
July 29, 2026 --
July 13, 2026 --
June 18, 2026 --
May 08, 2026 --
May 07, 2026 --
May 06, 2026 --
March 25, 2026 --
March 10, 2026 --
February 26, 2026 --
February 25, 2026 --
February 20, 2026 --
January 23, 2026 --
December 08, 2025 --
Date Value
December 01, 2025 --
November 07, 2025 --
November 06, 2025 --
November 05, 2025 --
August 07, 2025 --
August 06, 2025 --
May 08, 2025 --
April 22, 2025 --
April 01, 2025 --
March 31, 2025 --
March 12, 2025 --
February 26, 2025 --
February 24, 2025 --
February 21, 2025 --
November 06, 2024 --
September 03, 2024 --
August 06, 2024 --
May 09, 2024 --
May 08, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Moderna, Inc. Upgrade
Vir Biotechnology, Inc. Upgrade
Revolution Medicines, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade